Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
Kim S, Suarez-Almazor M. Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. Expert Review Of Clinical Immunology 2018, 15: 211-213. PMID: 30589372, DOI: 10.1080/1744666x.2019.1559731.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Agents, ImmunologicalHumansImmunotherapyNeoplasmsPractice Guidelines as Topic